Kazue Okajima

Kazue Okajima practices at Boston VA Healthcare System in West Roxbury, Massachusetts.

Kazue Okajima's NPI, 1568710010, was assigned on August 15, 2012. Kazue Okajima graduated from Osaka University Medical School in 1997. Kazue Okajima holds Texas license S1202.

Kazue Okajima's primary practice is Boston VA Healthcare System, at 1400 Vfw Pkwy, West Roxbury, MA 02132 in Suffolk County. The practice phone is (717) 277-6565.

Kazue Okajima's primary practice is Boston VA Healthcare System in West Roxbury, Massachusetts. The medical group on file is Texas Tech Physicians of El Paso. Dmand AI also links Kazue Okajima to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kazue Okajima practices. Vendor and product names are available with a free account.

Cardiovascular disease is Kazue Okajima's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Kazue Okajima is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Kazue Okajima's licenses on file in 3 states: Texas, Massachusetts and Hawaii.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension, coronary artery disease, heart blockage, heart failure, heart valve disorders and tobacco use among the conditions Kazue Okajima treats.

CMS data shows 768 Medicare services from Kazue Okajima across 11 procedure codes in 2024, for 477 Medicare patients. Medicare paid $18,569 for them.

CMS counts 477 Medicare patients who saw Kazue Okajima in 2024. The largest group is 65 to 74, with 178 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kazue Okajima's median patient age at 69, with 43% women.

In 2024, Kazue Okajima wrote 556 Medicare Part D claims for 118 patients. 80% of them were for generic drugs. CMS names the drug for 481 of them, across 15 drugs with 11 or more claims each, at $106,109 in total drug cost. In 2023, CMS named 375 claims across 12 drugs.

Dmand AI links 11 papers to Kazue Okajima, published from 2011 to 2025. 2021 was the busiest year, with 2. The most frequent topics are Blood Pressure. Kazue Okajima's most frequent co-authors are Marco Raffaele Di Tullio, MD, Shunichi Homma, MD and Mitchell S. Elkind, MD.

CMS Open Payments shows 89 general payments to Kazue Okajima from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. HeartFlow, Inc. paid the most, $1,705.

Kazue Okajima graduated from Osaka University Medical School in 1997.

Kazue Okajima is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.